FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition is made in the form of nasal cream containing an active substance of dioxotetrahydroxytetrahydronaphthalene and exicipients such as citric acid monohydrate, poloxamer 338, macrogol 20 cetostearyl ether, cetostearyl alcohol, solid paraffin, liquid paraffin, dimethicone 100 and propylene glycol.
EFFECT: stability when stored at temperatures above 25 degrees.
2 cl, 15 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINED SOFT DOSAGE FORM FOR TREATING HAEMORRHOID DISEASES | 2018 |
|
RU2705794C1 |
ANTIBACTERIAL PHARMACEUTICAL COMPOSITION OF CLOTRIMAZOLE AND METHOD FOR MAKING IT | 2013 |
|
RU2543655C1 |
TRANSDERMAL AGENT FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES, METHOD FOR PRODUCTION THEREOF AND COMBINED TRANSDERMAL PREPARATION FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES | 2013 |
|
RU2582278C2 |
PHARMACEUTICAL COMPOSITION IN FORM OF FOAM AEROSOL POSSESSING ANTI-INFLAMMATORY, REGENERATIVE AND ANTIMICROBIAL ACTION, AND METHOD FOR PREPARING IT | 2013 |
|
RU2542448C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING SKIN ITCHING | 2012 |
|
RU2543326C2 |
DIOXOTETRAHYDROXYTETRAHYDRONAPHTHALENE DOSAGE FORM | 2015 |
|
RU2677338C2 |
COMBINED PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION | 2018 |
|
RU2736940C2 |
DRUG FOR TREATING OSTEOARTHROSIS (VERSIONS) | 2013 |
|
RU2538218C2 |
MEDICATION FOR TREATING DERMATOSIS (VERSIONS) | 2013 |
|
RU2548764C2 |
CALCIPOTRIOL MONOHYDRATE NANOCRYSTALS | 2010 |
|
RU2555339C2 |
Authors
Dates
2017-05-03—Published
2016-05-25—Filed